Latest Post

March 12, 2021

Is home-based administration possible? Exploring the intravenous to subcutaneous transition in cancer treatments.

Imagine self-administered cancer treatments in the comfort of a patient&rsquo;s home. How close are we to making this a reality? During this unprecedented time, immuno-compromised patients can benefit from receiving a self-administered, home-based treatment option. One major factor into making home-based cancer treatment a reality is a focus on shifting the route of administration from intravenous to subcutaneous delivery. Due to an emphasis on patient involvement in shared decision making for health care policy and medical approaches, understanding the intravenous to subcutaneous transition in medical injections has garnered increased importance. If therapeutic efficacy is not compromised, the less invasive nature and convenience of subcutaneous injections is often the preferred route of administration.<sup>1-2,4-6</sup>
Aaron Chapman

Aaron Chapman, PhD

Program Manager, Commercial Technology Development

Previous Posts
Cancer Patient getting treatment

February 04, 2021

West Recognizes World Cancer Day 2021

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Patient with nurse getting treatment

September 16, 2020

Why a Diagnosis of Leukemia Means a Possibly Complicated Journey Ahead

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

SmartDose Platform

June 27, 2019

Industry Trends in Biologic Formulations

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

CPhI China Tradeshow

June 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

SmartDose In-Use

May 07, 2019

The Impact Poor Formulations Have on Drug Development Programs

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Load more